Zencore Biologics is a biologics contract development and manufacturing organisation supporting the development and manufacturing of drugs from the pre-clinical stage to commercial-stage manufacturing.
* Sofina has an observer seat in the decision-making bodies of the company.
Established in 2017, Zencore Biologics is a fast-growing biologics CDMO based in Shanghai, China, that provides end-to-end, one-stop shop solutions to clients for the contract development and manufacturing of biologics from the pre-clinical stage to commercial-stage manufacturing. To date, the company has served more than 100 biopharma and biotech customers and has completed over 150 projects, ranging from cell line development projects to Investigational New Drug applications and large commercial production contracts. Over the years, Zencore Biologics has developed deep expertise across monoclonal and bispecific antibodies, Antibody Drug Conjugates (ADCs), fusion proteins and vaccines.
Sofina invested in Zencore Biologics in 2021, notably next to LYFE Capital and Qiming.
China | 2021